Gastrointestinal Endoscopy
Volume 68, Issue 5 , Pages 867-876 , November 2008

Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up

Received 13 August 2007 ,Accepted 3 March 2008.

References 

  1. Peters JH, Hagen JA, DeMeester SR. Barrett's esophagus. J Gastrointest Surg. 2004;8:1–17
  2. Reid BJ. Barrett's esophagus and adenocarcinoma. Gastroenterol Clin North Am. 1991;20:817–834
  3. Shaheen N, Ransohoff DR. Gastroesophageal reflux, Barrett's esophagus and esophageal cancer. JAMA. 2002;287:1972–1981
  4. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology. 1990;99:918–922
  5. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–1831
  6. Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125:1670–1677
  7. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology. 2002;123:636–639
  8. Labenz J, Nocon M, Lind T, et al. Prospective follow-up data from the ProGERD Study suggest that GERD is not a categorical disease. Am J Gastroenterol. 2006;101:2457–2462
  9. Kendall BJ, Whiteman DC. Temporal changes in the endoscopic frequency of new cases of Barrett's esophagus in an Australian health region. Am J Gastroenterol. 2006;101:1178–1182
  10. Shaheen NJ. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 2005;128:1554–1566
  11. Chandrosoma P, Wickramasinghe K, Ma Y, et al. Is intestinal metaplasia a necessary precursor lesion for adenocarcinoma of the distal esophagus, gastroesophageal junction and gastric junction?. Dis Esophagus. 2007;20:36–41
  12. Shaheen NJ, Crosby MA, Bozymski EM, et al. Is there a publication bias in reporting cancer risk in Barrett's esophagus?. Gastroenterology. 2000;119:333–338
  13. Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2006;4:566–572
  14. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol. 1997;92:212–215
  15. Rudolph RE, Vaughan TL, Storer BE, et al. Effect of segment length on risk for neoplastic progression in patients with Barrett's esophagus. Ann Intern Med. 2000;132:612–620
  16. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol. 1999;94:2037–2042
  17. Robertson CS, Mayberry JF, Nicholson DA, et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's esophagus. Br J Surg. 1988;75:760–763
  18. Hameeteman , Tytgat GN, Houthoff HJ, et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989;96:1249–1256
  19. Vaughan TL, Dong LM, Blount PL, et al. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol. 2005;6:945–952
  20. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 2002;97:1888–1895
  21. Overholt BF, Lightdale CJ, Wang KK, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc. 2005;62:488–498
  22. Webber J, Herman M, Kessel D, et al. Current concepts in gastrointestinal photodynamic therapy. Ann Surg. 1999;230:12–23
  23. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology. 2000;118:670–677
  24. Seewald S, Akaraviputh T, Seitz U, et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc. 2003;57:854–859
  25. Gossner L, May A, Stolte M, et al. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc. 1999;49:8–12
  26. Ginsberg GG, Barkun AN, Bosco JJ, et al. The argon plasma coagulator. Gastrointest Endosc. 2002;55:807–810
  27. Dulai GS, Jensen DM, Cortina G, et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc. 2005;61:232–240
  28. Montes CG, Brandalise NA, Deliza R, et al. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. Gastrointest Endosc. 1999;50:173–177
  29. Sampliner RE, Faigel D, Fennerty MB, et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc. 2001;53:554–558
  30. Johnston MH, Eastone JA, Horwhat JD, et al. Cryoablation of Barrett's esophagus: a pilot study. Gastrointest Endosc. 2005;62:842–848
  31. Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007;65:185–195
  32. Ganz RA, Utley DS, Stern RA, et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc. 2004;60:1002–1010
  33. Dunkin BJ, Martinez J, Bejarano PA, et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device (BÂRRX). Surg Endosc. 2006;20:125–130
  34. Smith CD, Bejarano PA, Melvin WS, et al. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc. 2007;21:560–569
  35. Shaheen NJ, Dulai GS, Ascher B, et al. Effect of a new diagnosis of Barrett's esophagus on insurance status. Am J Gastro. 2005;100:577–580

 Presented at Digestive Disease Week, May 20-23, 2007, Washington, DC (Gastrointest Endosc 2007;65:AB135).

 See CME section; p. 960.

PII: S0016-5107(08)00381-7

doi: 10.1016/j.gie.2008.03.008

Gastrointestinal Endoscopy
Volume 68, Issue 5 , Pages 867-876 , November 2008

Article Tools

* Image Usage & Resolution